Diabetes Complications: Short-Term and Long-Term Risks

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider regarding any medical condition or treatment.

Key Takeaways

  • Diabetes complications split into short-term emergencies (DKA, HHS, hypoglycemia) and long-term chronic damage.
  • Long-term complications include cardiovascular disease, kidney disease, retinopathy, and neuropathy.
  • Cardiovascular disease is the leading cause of death in people with diabetes, accounting for about 65% of mortality.
  • Tight blood sugar, blood pressure, and lipid control reduces complication risk by 30-50% across most categories.
  • Annual eye exams, kidney function tests, and foot checks catch complications early, when they are most treatable.

Diabetes complications fall into two broad categories: short-term emergencies that develop over hours to days, and long-term damage that develops over years. Short-term complications include diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS), and hypoglycemia. Long-term complications include cardiovascular disease, kidney disease, eye damage, and nerve damage. Tight control prevents most of them.

Short-Term (Acute) Complications

Diabetic Ketoacidosis (DKA)

DKA is a life-threatening complication that primarily affects type 1 diabetes, though it can occur in type 2. When the body cannot use glucose for energy (usually due to severe insulin deficiency), it breaks down fat rapidly, producing acidic ketones that build up in the blood.

  • Triggers: Missed insulin doses, infection, heart attack, SGLT-2 inhibitors (rare)
  • Symptoms: Nausea, vomiting, abdominal pain, fruity breath, rapid breathing, confusion
  • Labs: Glucose above 250 mg/dL, ketones positive, blood pH below 7.3
  • Treatment: IV fluids, insulin drip, electrolyte replacement in the hospital
  • Mortality: Under 1% with prompt treatment; higher in older adults

Hyperosmolar Hyperglycemic State (HHS)

HHS is the type 2 version of a severe hyperglycemic emergency. Blood sugar climbs extremely high (often above 600 mg/dL), but ketones stay low because the person still produces some insulin. HHS has a higher mortality than DKA.

  • Triggers: Infection (pneumonia, UTI), stroke, heart attack, dehydration, certain medications
  • Symptoms: Severe thirst, frequent urination, weakness, confusion, coma
  • Labs: Glucose often 600-1,200 mg/dL, serum osmolality high, minimal ketones
  • Treatment: IV fluids first, then insulin, then electrolyte correction
  • Mortality: 5-20% due to advanced age and comorbidities

Hypoglycemia (Low Blood Sugar)

Hypoglycemia is the opposite problem: blood sugar drops too low, typically below 70 mg/dL. It is most common in people using insulin or sulfonylureas.

Level Glucose Symptoms Action
Level 1 (alert) 54-69 mg/dL Shaky, sweaty, hungry 15g fast carbs; recheck in 15 min
Level 2 (serious) Below 54 mg/dL Confusion, weakness, slurred speech Treat immediately; may need help
Level 3 (severe) Unconscious / seizure Cannot self-treat Glucagon injection; call 911

Long-Term (Chronic) Complications

Cardiovascular Disease (CVD)

Cardiovascular disease is the single biggest threat to people with diabetes. According to the CDC, adults with diabetes are twice as likely to have heart disease or stroke as those without. About 65% of diabetes deaths are due to cardiovascular causes.

  • Coronary artery disease (heart attack)
  • Stroke (ischemic and hemorrhagic)
  • Peripheral artery disease (leg and foot circulation problems)
  • Heart failure
  • Atrial fibrillation

Risk reduction focuses on three targets: A1C under 7.0%, blood pressure under 130/80 mmHg, and LDL cholesterol under 100 mg/dL (or under 70 for very high risk). Statins, ACE inhibitors, and newer drugs like SGLT-2 inhibitors and GLP-1 agonists significantly reduce events.

Kidney Disease (Diabetic Nephropathy)

Diabetes is the leading cause of kidney failure in the United States, accounting for about 47% of new cases of end-stage renal disease.

Stages of diabetic kidney disease:

  1. Stage 1: Kidney damage with normal filtration (GFR 90+, albumin in urine)
  2. Stage 2: Mild GFR decline (60-89)
  3. Stage 3: Moderate decline (30-59), may need medication adjustments
  4. Stage 4: Severe decline (15-29), nephrologist referral
  5. Stage 5: Kidney failure (below 15), dialysis or transplant

Annual screening with urine albumin-to-creatinine ratio and serum creatinine catches early damage. ACE inhibitors, ARBs, and SGLT-2 inhibitors slow progression. See our guide on diabetic kidney disease.

Eye Disease (Diabetic Retinopathy)

Diabetic retinopathy is the leading cause of blindness in working-age adults. Over 30% of people with diabetes have some form.

  • Non-proliferative retinopathy: Microaneurysms and small hemorrhages; often no symptoms early on.
  • Macular edema: Fluid leaks into the central retina; distorts vision.
  • Proliferative retinopathy: New fragile vessels grow; can cause catastrophic bleeding or retinal detachment.
  • Diabetic macular edema: Treated with anti-VEGF injections (Lucentis, Eylea, Avastin).

Annual dilated eye exams are non-negotiable. Diabetes also raises risk of cataracts and glaucoma.

Nerve Damage (Diabetic Neuropathy)

Up to 50% of people with diabetes develop some form of neuropathy. The four types are peripheral, autonomic, focal, and proximal. Peripheral neuropathy is by far the most common, causing numbness, tingling, and pain in feet and hands. Autonomic neuropathy can affect heart rate, digestion, and bladder function.

For a deeper dive, see our guide to neuropathy and tingling.

Foot Complications

The combination of neuropathy (lost sensation) and peripheral artery disease (poor circulation) creates a dangerous situation. About 15% of people with diabetes develop a foot ulcer, and 14-24% of those ulcers lead to amputation.

  • Daily foot inspection (use a mirror or ask a partner)
  • Never walk barefoot
  • Wear well-fitted shoes and moisture-wicking socks
  • Treat any wound aggressively — see a doctor within 24 hours

Other Long-Term Complications

Complication Description Risk vs non-diabetic
Gum disease (periodontitis) Inflammation and bone loss 2-3x higher
Skin infections Bacterial and fungal 2-4x higher
Sleep apnea Strongly linked to type 2 diabetes 2x higher
Fatty liver (NAFLD) Fat accumulation in the liver 2-3x higher
Depression Bidirectional relationship 2x higher
Cognitive decline / dementia Especially vascular dementia 50-100% higher
Certain cancers (pancreas, liver, colon) Modestly increased risk 20-100% higher
Hearing loss Often overlooked 2x higher

Prevention Framework: The ABCs Plus

Most complications are preventable or delayable with systematic management.

  • A — A1C under 7.0% (personalize with your doctor)
  • B — Blood pressure under 130/80 mmHg
  • C — Cholesterol (LDL) under 100 mg/dL, or 70 if very high risk
  • D — Do not smoke
  • S — Stop by for routine screenings

The 1998 UKPDS landmark study showed that tight glucose control reduced microvascular complications by 25% in type 2 diabetes. Combined ABC control reduces complication risk by 30-50% across the board.

Annual Screening Checklist

  1. A1C every 3 months (if not at goal) or every 6 months (if stable)
  2. Dilated eye exam every year
  3. Urine albumin-to-creatinine ratio yearly
  4. Serum creatinine / eGFR yearly
  5. Comprehensive foot exam yearly
  6. Lipid panel yearly
  7. Dental cleaning every 6 months
  8. Blood pressure at every visit
  9. Depression screening yearly
  10. Immunizations: flu annually, pneumococcal, shingles (age 50+), COVID-19

For a deeper walkthrough of major complications, see our full guide on related conditions and the prediabetes 101 hub.

The Bottom Line

Diabetes complications range from acute emergencies (DKA, HHS, hypoglycemia) to long-term damage of the heart, kidneys, eyes, nerves, and feet. Cardiovascular disease is the leading cause of death, but the most common complications are neuropathy and retinopathy. Aggressive control of A1C, blood pressure, and cholesterol — combined with yearly screenings — cuts risk by 30-50%. The difference between a person with diabetes who lives a full, healthy life and one who suffers complications is almost always in the daily management.

Frequently Asked Questions

What are the most common diabetes complications?

The most common complications are cardiovascular disease (heart attack, stroke), neuropathy (nerve damage), retinopathy (eye damage), and nephropathy (kidney damage). Cardiovascular disease is the leading cause of death. Roughly half of people with diabetes will develop some form of neuropathy during their lifetime. Regular screening catches most early.

What is the life expectancy of someone with diabetes?

Type 2 diabetes reduces life expectancy by about 6 years on average, according to CDC data. Type 1 diabetes reduces it by 8-13 years. However, people who achieve and maintain tight glucose, blood pressure, and cholesterol control have life expectancy approaching non-diabetic peers. Smoking and cardiovascular disease are the biggest modifiers.

Which diabetes complication is most deadly?

Cardiovascular disease is the leading cause of death in diabetes, responsible for about 65% of mortality. Diabetes doubles the risk of heart attack and stroke. Diabetic ketoacidosis and hyperosmolar hyperglycemic state are acute emergencies that can be fatal if untreated but are highly treatable with prompt care.

Can diabetes complications be reversed?

Some can be partially reversed with aggressive control; others cannot. Early kidney disease and retinopathy can stabilize or regress with tight glucose and blood pressure control. Established neuropathy is typically permanent, though progression can be halted. Scarring and structural damage, such as vision loss from untreated retinopathy, is usually irreversible.

How often should I be screened for diabetes complications?

The ADA recommends: A1C every 3-6 months, annual dilated eye exam, annual urine albumin test and blood creatinine for kidneys, annual comprehensive foot exam, lipid panel yearly, and blood pressure at every visit. Type 1 diabetes screening starts at age 11 or 5 years after diagnosis. Type 2 screening starts at diagnosis.

Sources

  1. American Diabetes Association. Standards of Care in Diabetes. Diabetes Care, 2024.
  2. Centers for Disease Control and Prevention. Diabetes Complications. https://www.cdc.gov/diabetes/data/statistics-report/index.html
  3. UK Prospective Diabetes Study Group. Intensive blood-glucose control reduces complications. The Lancet, 1998.
  4. National Institute of Diabetes and Digestive and Kidney Diseases. Preventing Diabetes Problems.